On Monday, iKang Healthcare Group Inc (ADR) (NASDAQ:KANG)’s shares inclined 7.15% to $22.18.
iKang Healthcare Group Inc (ADR) (KANG) declared that it will release its unaudited financial results for the fourth quarter and the fiscal year ended March 31, 2015 on June 8, 2015 after the US market closes.
iKang Healthcare Group, Inc., together with its auxiliaries, provides preventive healthcare solutions in the People’s Republic of China. The company offers a range of medical examinations, which comprise internal, gynecology, ophthalmology, ENT, dental, lab tests, electrocardiogram, ultrasound, and X-ray examination items.
Biocept Inc (NASDAQ:BIOC)’s shares gained 5.81% to $3.28.
Biocept Inc (BIOC) declared receipt of a U.S. patent for its blood collection and transport preservative. The patent, entitled USE OF DIAZOLIDINYL UREA FOR ANTI-CLUMPING OF BIOLOGICAL SAMPLES, was issued as U.S. Patent No. 9,040,255.
The granted patent covers Biocept’s blood collection preservative contained in the tube for collecting patient blood used for circulating tumor cell (CTC) and circulating tumor DNA (ctDNA) genomic analysis at Biocept. The patented collection preservative significantly reduces clumping of cells that may interfere with their capture when using microchannels and other devices for up to 96 hours, preserving specimen integrity in order to allow Biocept to perform testing for patients worldwide. Other preservatives for blood are limited to 24 hours, therefore compromising the ability to offer many types of testing globally. This patent further expands the intellectual property protection of the tools Biocept uses for its liquid biopsy analysis.
Biocept, Inc., a cancer diagnostics company, develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA tests utilizing a standard blood sample. The company’s tests provide information to oncologists that enable them to select the appropriate treatment for their patients based on detailed data on the characteristics of tumors.
At the end of Monday’s trade, Invesco Ltd. (NYSE:IVZ)‘s shares surged 0.10% to $39.87.
Invesco Ltd. (IVZ) is planned to present at the 2015 Morgan Stanley Financials Conference to be held in New York, NY on June 9, 2015, at about 2:25 pm ET. John Anzalone, Chief Investment Officer, is planned to speak.
Invesco Ltd. is a publicly owned investment manager. The firm provides its services to retail clients, institutional clients, high-net worth clients, public entities, corporations, unions, non-profit organizations, endowments, foundations, pension funds, financial institutions, and sovereign wealth funds. It manages separate client focused equity, balanced, and fixed income portfolios.
Tyson Foods, Inc. (NYSE:TSN), ended its Monday’s trading session with -0.54% loss, and closed at $42.22.
Mexico’s Federal Economic Competition Commission has approved the sale of Tyson Foods, Inc.’s (TSN) poultry business in Mexico to Pilgrim’s Pride, which is part of a wholly-owned subsidiary of JBS SA (JBSAY).
The commission, which has been reviewing the transaction, recently voted to permit the deal to proceed.
Tyson Foods and Pilgrim’s Pride reached a definitive agreement on the sale last July. The Mexican business, known as Tyson de Mexico, is a vertically integrated poultry business based in Gomez Palacio in North Central Mexico. It employs more than 5,400 people in its offices, three plants and seven distribution centers.
After the sale is completed, Tyson Foods will continue to serve customers in Mexico. The company will supply them with U.S.-produced chicken as well as chicken produced in Mexico, in part through a co-packaging arrangement with Pilgrim’s Pride.
Tyson Foods, Inc., together with its auxiliaries, produces, distributes, and markets chicken, beef, pork, prepared foods, and related allied products worldwide. The company breeds and raises chickens; and processes live chickens into fresh, frozen, and value-added chicken products.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
